newsfilter
← Latest News
PR Newswire·

Kindred Biosciences Announces COVID-19 Vaccine Manufacturing Agreement with Vaxart

Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company developing novel biologics, today announced it has entered into an agreement...